Chlorine Dioxide for Swimming Pools

    An evidence-led guide for commercial pool operators considering chlorine dioxide: by-product and biofilm evidence, site-specific verification, GB BPR transitional supply, and the continuing need for filtration or UV barriers.

    Product guidance
    Expert Reviewed

    Swimming pool water treatment has long relied on chlorine. As understanding of disinfection by-products has advanced, some commercial pool operators are evaluating chlorine dioxide (ClO₂) as part of a site-specific treatment programme. ClO₂ has a different by-product profile from free chlorine, but it is not a universal drop-in replacement: biofilm efficacy, swimmer comfort, compatibility, ventilation, operating cost and regulatory suitability must all be demonstrated for the particular product and pool. It forms chlorite and chlorate, and it cannot be relied upon to control Cryptosporidium, so an effective independent filtration or validated UV barrier remains essential. This guide explains the questions commercial pool operators, leisure centre managers and facilities teams should address.

    The Problem with Chlorine in Swimming Pools

    Chlorine has been the standard swimming pool disinfectant for decades, and it remains effective at killing many waterborne pathogens in the bulk water. However, chlorine's interaction with organic matter introduced by bathers - sweat, skin cells, urine, cosmetics, sunscreen - creates a range of disinfection by-products (DBPs) that pose genuine health concerns for swimmers and pool staff.

    The most significant of these by-products are chloramines - specifically mono-, di-, and trichloramine. Trichloramine is highly volatile and is the primary cause of the distinctive 'chlorine smell' in indoor pool halls. Despite the common perception, this smell does not indicate a clean pool - it indicates a high concentration of combined chlorine (chloramines) in the water and air. Trichloramine is a known respiratory irritant and has been linked to occupational asthma in pool workers and lifeguards, as well as increased respiratory symptoms in competitive swimmers and children who swim regularly.

    Chlorine can also form trihalomethanes (THMs), including chloroform, when it reacts with organic matter. Exposure can occur through inhalation and skin contact. The World Health Organization discusses THMs in its recreational-water guidance. The 100 µg/L total-THM standard in UK drinking-water regulations is useful context but is not a swimming-pool limit; pool operators should instead follow the standards and risk controls applicable to their facility.

    Beyond by-products, chlorine's efficacy is heavily pH-dependent. At pH 7.2 (the lower end of the acceptable range for pool water), approximately 65% of free chlorine is in the active hypochlorous acid form. At pH 7.8 (the upper end), this drops to around 30%. This means pool operators must maintain tight pH control to ensure adequate disinfection - a challenge that consumes significant operational time and chemical cost.

    How Chlorine Dioxide Works as a Pool Chlorine Alternative

    Chlorine dioxide is a dissolved gas with the molecular formula ClO₂. Despite the similar name, it is chemically distinct from chlorine. It acts by oxidation rather than by providing a free-chlorine residual. It does not form chloramines and generally forms much less THM and HAA than hypochlorite under comparable conditions, but it does form inorganic chlorite and chlorate and nontarget studies show that 'zero halogenated by-products' is not a defensible claim. A site programme must monitor the by-products and operating parameters specified by the product documentation and applicable pool standards.

    Chlorine dioxide does not form chloramines, but that difference does not establish odour, eye, respiratory, air-quality or equipment-life outcomes for a pool. Bather hygiene, water balance, aerosols, other chemicals and ventilation still matter, and indoor-pool ventilation must remain adequate.

    Chlorine dioxide performance is generally less pH-dependent than free chlorine within normal pool operating conditions, but it is not independent of the whole water matrix. Temperature, organic demand, contact time, hydraulics and maintained residual affect performance. Operators must continue to control pH and every other parameter required by PWTAG guidance, the product label and their written operating procedures.

    Comparisons based only on theoretical oxidising capacity do not establish an equivalent pool dose. No default chlorine dioxide concentration is asserted safe or effective by this guide. Product-specific conditions, a competent site assessment, validated monitoring and the applicable pool guidance must determine dosing and contact time.

    Biofilm Control in Pool Pipework and Plant

    Chlorine dioxide may contribute to control of some biofilms under validated, system-specific conditions; this is not a guarantee of removal in a pool circulation system. Biofilm can develop on pipe walls, filter media, heat exchangers and balance tank surfaces and may harbour organisms including Pseudomonas aeruginosa, Legionella pneumophila and non-tuberculous mycobacteria. Its matrix can protect organisms from disinfectant exposure.

    Disinfectant can be consumed by the organic matter in a biofilm's extracellular polymeric substance (EPS) matrix, so an acceptable bulk-water result does not by itself prove that pipework and plant are free of biofilm. The extent of penetration depends on disinfectant demand, biofilm thickness, concentration and contact time.

    Published studies report biofilm effects under defined organism, matrix, surface, concentration and contact-time conditions. They do not establish removal or inactivation throughout a particular pool system. Physical cleaning, filtration management and remedial treatment may still be required; trend microbiological results and inspect accessible plant.

    For pools with a history of Pseudomonas issues, especially spa pools, hydrotherapy pools and interactive water features, a competent risk assessment should investigate hydraulics, filters, cleaning, bather loading and biofilm reservoirs. Chlorine dioxide may form one part of the control programme where the product conditions permit; it does not replace those controls or routine microbiological verification.

    Commercial Pool Water Treatment: Operational Assessment

    Commercial pool operators manage complex programmes that balance microbiological control, bather comfort, regulatory compliance, water chemistry, energy use and cost. Chlorine dioxide may offer operational benefits, but none should be assumed before a controlled, site-specific evaluation.

    Because chlorine dioxide does not form a combined-chlorine residual, chloramine-specific interventions may differ, but no reduction in chemical use, closures or treatment demand should be assumed. Measure outcomes against a documented baseline.

    Avoiding chloramines may reduce one contaminant load on indoor-pool ventilation, but it does not justify reducing ventilation automatically. Ventilation also controls humidity, temperature, aerosols and other contaminants. Any change must follow a competent air-quality and building-services assessment and continue to meet occupational-health and pool-design requirements.

    Fresh-water replacement remains necessary for bather pollution and dissolved substances, including any chlorite and chlorate generated by treatment. Operators should not reduce dilution merely because chlorine dioxide is used; changes must be supported by measured water quality and applicable PWTAG guidance.

    Biofilm control may improve plant condition in some systems, but claims about longer filter runs, heat-transfer efficiency or equipment life require site evidence. Filtration, backwashing, physical cleaning and planned maintenance remain essential.

    Swimmer Health and Comfort

    A change in chloramine formation does not establish an odour, irritation or health outcome. Comfort depends on water balance, dose control, bather pollution, ventilation and individual sensitivity.

    Research has examined associations between indoor-pool exposures and respiratory symptoms, including in children, but an association does not prove that changing one disinfectant will remove every risk. Swimming schools and family facilities should base decisions on a full risk assessment and measured water and air quality, not on a blanket 'safer' claim.

    Pool workers and lifeguards can experience prolonged exposure to trichloramine in poorly controlled indoor pools. Where a change in treatment reduces measured trichloramine, that may improve one aspect of exposure control, but occupational-health monitoring and adequate ventilation remain necessary.

    People with eczema or other sensitivities can respond differently to any treated pool. Operators should not promise that chlorine dioxide will prevent irritation or improve a medical condition. Maintain chemistry within the applicable limits, investigate complaints and advise individuals to seek appropriate clinical guidance.

    Regulatory Compliance for Pool Chlorine Dioxide Treatment

    Swimming-pool disinfectants fall within GB BPR Product Type 2 (PT2). A product placed on the Great Britain market must either hold the relevant product authorisation or be lawfully supplied under applicable transitional arrangements; not every lawful transitional product has an authorisation number or appears on the authorised-products list. Article 95 listing is a separate supply-chain requirement, not product authorisation or evidence of efficacy.

    Verification must follow the applicable route. For an authorised product, check the HSE authorisation number and conditions for the proposed PT2 use. Otherwise obtain evidence for the specific chlorine dioxide active-substance or precursor route and PT2 combination in the GB Review Programme, the relevant GB Article 95 supply chain, applicable transitional requirements and deadlines, and any other national requirements. ChloroKlean products for their stated uses are supplied in Great Britain under GB BPR transitional arrangements while the relevant chlorine dioxide combinations are in the Review Programme; no full product authorisation, EU authorisation or Northern Ireland authorisation is claimed.

    Pool water quality management should follow the guidance in PWTAG (Pool Water Treatment Advisory Group) standards, which set out requirements for microbiological quality, chemical parameters, and operational practices. While PWTAG standards were developed primarily for chlorinated pools, the principles of regular monitoring, proper circulation, and adequate turnover apply equally to chlorine dioxide-treated pools.

    For swimming pools that also incorporate spa pools, hydrotherapy features or interactive water play equipment, assess which guidance applies; HSG282 specifically addresses spa-pool systems. Warm water, aerosols and complex shared plant can increase microbial risk. Any chlorine dioxide programme must be integrated with the written scheme, cleaning, circulation, filtration and monitoring rather than treated as a substitute for them. Neither chlorine nor chlorine dioxide can be relied upon to control Cryptosporidium: effective filtration and, where specified, validated UV provide the independent barrier.

    Key Data & Statistics

    PT2

    GB BPR product type covering disinfectants for swimming-pool water

    2 routes

    Lawful GB supply requires product authorisation or applicable transitional arrangements

    Independent barrier

    Effective filtration and, where specified, validated UV are essential for Cryptosporidium control

    HSG282

    HSE guidance specifically for spa-pool systems and associated infection risks

    Swimming Pool Disinfection Methods Compared

    How chlorine dioxide compares to conventional pool disinfection methods for commercial swimming pools.

    Feature comparison table
    FeatureChlorine DioxideChlorine (NaOCl)BromineUV + Chlorine
    Combined-disinfectant by-productsDoes not form chloramines; chlorite/chlorate require controlChloramines can form under bather loadBromamines and brominated by-products can formUV may reduce chloramines; chemical residual still forms by-products
    Indoor air implicationsAssess water and air quality; ventilation requiredAssess combined chlorine and ventilationSite-specific monitoring requiredAssess water and air quality; ventilation required
    Biofilm in PipeworkCan support control under validated conditions; cleaning still neededPerformance depends on demand, residual and cleaningPerformance depends on demand, residual and cleaningUV treats water passing the reactor, not remote pipe surfaces
    CryptosporidiumCannot be relied upon; independent barrier essentialCannot be relied upon at normal pool conditionsCannot be relied uponValidated UV can provide a barrier alongside effective filtration
    Water ClarityDepends on complete treatment trainGood when complete system is managedGood when complete system is managedDepends on filtration, coagulation and UV design
    Swimmer comfortNo chloramine formation; assess overall water and air qualityAssess combined chlorine and overall chemistryAssess overall water and air qualityAssess overall water and air quality
    GB BPR routeAuthorisation or lawful transitional supply for PT2Authorisation or lawful transitional supply for PT2Authorisation or lawful transitional supply for PT2UV device is separate; accompanying biocide still needs a lawful PT2 route
    Operating CostRequires site-specific whole-life assessmentRequires site-specific whole-life assessmentRequires site-specific whole-life assessmentCapital, lamp, energy and chemical costs vary by site

    Indicative comparison only. Confirm product-specific conditions, current GB BPR status and the complete treatment design. HSG282 applies to spa-pool systems; it is not a blanket swimming-pool approval. Article 95 listing is not product authorisation.

    How to Switch Your Swimming Pool from Chlorine to Chlorine Dioxide

    A step-by-step guide for commercial pool operators planning to transition from chlorine to chlorine dioxide water treatment.

    1

    Assess Your Current Pool Water Treatment System

    Document your existing treatment programme including chlorine type and concentration, dosing method, pH control, filtration system, circulation rates, and pool volumes. Record current chemical costs, combined chlorine levels, THM measurements (if available), and any history of microbiological issues. Note the ventilation capacity and any complaints about air quality or chlorine smell.

    2

    Contact ChloroKlean for a Pool Assessment

    Request a pool assessment from ChloroKlean by calling +44 333 772 7379 or emailing hello@chloroklean.com. Provide your pool details including volume, type (leisure, competition, teaching or hydrotherapy), water temperature, bather-load profile and current challenges. Confirm that the proposed product and use are within its supplied PT2 uses and obtain the product documentation needed for the site's technical and regulatory review.

    3

    Plan the Transition

    Prepare a site-specific transition plan covering system preparation, chemical compatibility, any remedial clean, dosing controls, residual and by-product monitoring, independent Cryptosporidium barriers, equipment requirements and acceptance criteria. Do not adopt a generic dose. Verify GB BPR status by the applicable route: authorisation number and conditions if authorised; otherwise the relevant precursor route plus PT2 Review Programme status, Article 95 supply chain, transitional requirements and deadlines, and any national requirements.

    4

    Conduct Initial Biofilm Removal and System Clean

    Where the risk assessment identifies a need, carry out a planned clean of the circulation system, balance tanks, filter vessels and associated pipework using methods and concentrations permitted by the relevant product documentation. Chemical treatment alone does not guarantee complete biofilm removal; combine it with appropriate physical cleaning, flushing and verification before reopening.

    5

    Establish Routine Dosing and Monitoring

    Implement only the site-specific regime permitted by the product documentation and accepted by the competent pool-water adviser. Monitor chlorine dioxide at the frequency and locations set by that regime, together with pH, temperature, turbidity, microbiological quality and specified by-products including chlorite and chlorate. Verify filtration or validated UV performance for Cryptosporidium control. Update pool management documentation, COSHH assessments, emergency arrangements and staff training.

    Expert Insights

    About the Reviewer

    Gavin Owen

    Managing Director, ChloroKlean

    Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.

    BPR Compliance
    Water Treatment
    Legionella Control
    Industrial Disinfection

    Related Products

    BPR-compliant chlorine dioxide products available from ChloroKlean.

    Frequently Asked Questions

    Common questions about this topic, answered by our technical team.

    It can be considered where the specific product is lawfully supplied under GB BPR for the intended PT2 use and the site programme satisfies applicable pool guidance. ChloroKlean products for their stated GB uses are supplied under transitional arrangements, not claimed to have full GB, EU or Northern Ireland product authorisation. Chlorine dioxide does not form chloramines and generally forms much less THM/HAA than hypochlorite, but chlorite, chlorate and operating performance must be monitored. Biofilm results depend on the system, dose and contact time and must be verified on site.

    Chlorine dioxide does not form chloramines, a major source of familiar combined-chlorine odour. That difference alone does not establish an odour or comfort outcome for a pool; other treatment chemicals, water balance, bather pollution and ventilation must be assessed.

    Chlorine dioxide is chemically distinct from free chlorine and does not form chloramines. Calling it 'chlorine-free' can nevertheless mislead: its formula contains chlorine, it forms chlorite and chlorate, and nontarget analysis does not support a claim of zero chlorinated organics. It should be assessed as a different oxidant with a different by-product profile, not as by-product-free treatment.

    Safety cannot be established from a generic concentration range. Use must follow the product-specific conditions, competent risk assessment, applicable pool standards and verified control of residual, chlorite, chlorate and other water-quality parameters. Avoiding chloramines may reduce one source of odour and irritation, but no treatment can promise no eye, skin or respiratory symptoms, including for children or people with sensitive skin.

    The answer is site-specific. Compare chemical and monitoring costs, dosing equipment, filtration, fresh water, heat, maintenance, staff time and verified treatment performance against a measured baseline. Do not assume ventilation can be reduced, dilution can be cut or equipment life will increase solely because chlorine dioxide is used. ChloroKlean can prepare a site-specific comparison for technical review.

    Potentially, but a shared programme must not be assumed. Pools and spa-pool systems have different temperatures, loads, hydraulics, monitoring needs and guidance; HSG282 applies specifically to spa-pool systems. Confirm that the product's lawfully supplied PT2 uses and conditions cover each application, then validate separate control targets and monitoring. ChloroKlean claims GB transitional supply for stated uses, not full PT2 product authorisation.

    It cannot be relied upon to do so. Chlorine dioxide is not a dependable Cryptosporidium barrier at normal pool operating conditions. Effective filtration and, where the risk assessment and design require it, validated UV must provide an independent barrier, supported by incident procedures and verification.

    Important Safety Information for Pool Operators

    • A swimming-pool disinfectant must be lawfully supplied in Great Britain for its intended PT2 use, either under a product authorisation or applicable transitional arrangements. A lawful transitional product may have no authorisation number and may not appear on the authorised-products list.
    • For an authorised product, verify its HSE authorisation number and conditions. Otherwise verify the specific active-substance or precursor route plus PT2 Review Programme status, Article 95 supply chain, applicable transitional requirements and deadlines, and any other national requirements. Article 95 listing is not product authorisation.
    • Chlorine dioxide products must be stored, handled, and dosed in accordance with the product Safety Data Sheet, label directions, and COSHH assessment.
    • Use the personal protective equipment specified by the Safety Data Sheet and site COSHH assessment when handling concentrated products; required glove, eye and face protection depends on the product and task.
    • Pool water quality must be monitored in accordance with applicable PWTAG standards and, for spa-pool systems, HSG282 guidance. Include specified chlorine dioxide residual and by-product checks; no generic dose in this guide overrides product-specific conditions.
    • Neither chlorine nor chlorine dioxide can be relied upon for Cryptosporidium control. Maintain and verify effective filtration and any specified validated UV barrier.
    • Never mix chlorine dioxide products with chlorine, acid, or any other pool chemicals unless specified in the product documentation.
    • Maintain adequate ventilation in indoor pool environments regardless of the disinfectant used. Monitor air quality in accordance with occupational health requirements.

    This information is provided for guidance only and does not replace the product Safety Data Sheet, product-specific conditions, COSHH assessment, PWTAG guidance or HSG282. ChloroKlean products for stated Great Britain uses are supplied under GB BPR transitional arrangements; no full GB product authorisation or EU/Northern Ireland authorisation is claimed. Pool operators should obtain competent advice for their installation and confirm all applicable requirements.

    Related Resources

    Continue exploring our knowledge base and product information.

    Sources & References

    This article references guidance from the following authoritative sources:

    External links open in a new window. ChloroKlean is not responsible for the content of external websites.

    Need Help Choosing the Right Product?

    Our technical team can advise on product selection, dosing, and compliance for your specific application.